Provider
P14-24 Medicare Part B Step Therapy Program Expansion to Include Rystiggo, and Vyvgart Hytrulo
Program effective Date: Mar 01, 2024
Documents & Forms Results
Displaying 481 - 490 of 3754 results
Provider
P54-24 Changes to the Medication Therapy Management (MTM) Program, Effective January 1, 2025
Program effective Date: Sep 03, 2024
Provider
P57-24 MagellanRx Management, a Prime Therapeutics Company (UM) Program: Medical Drug Updates
Program effective Date: Sep 03, 2024
Provider
2024 September Bulletins
Program effective Date: Sep 03, 2024
Provider
P45R1-24 Updated Reimbursement Policies, Effective September 3, 2024
Program effective Date: Sep 03, 2024
Provider
P55-24 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
Program effective Date: Sep 03, 2024
Provider
QP68-24 MHCP Pharmacy Benefit Exclusion for Kisunla™, PiaSky®, and Tecelra®
Program effective Date: Aug 28, 2024
Provider
QP67-24 Commercial Pharmacy Benefit Exclusion for edaravone, Kisunla™, PiaSky®, and Tecelra®
Program effective Date: Aug 28, 2024
Provider
QP65-24 PCA Agency Requirements
Program effective Date: Aug 28, 2024
Provider
QP66-24 Reminder: Patient Complaint Policy and Process Requirements
Program effective Date: Aug 28, 2024